Continuous renal replacement therapy (CRRT) in the intensive care unit

Journal of Intensive Care Medicine

Volumn 13, Issue 2, 1998, Pages 85-105

  Kaplan, Andre A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULATION; BIOCOMPATIBILITY; CONTINUOUS INFUSION; DIALYSIS; FILTER; HEMOFILTRATION; HUMAN; INTENSIVE CARE UNIT; KIDNEY TRANSPLANTATION; PARENTERAL NUTRITION; PRIORITY JOURNAL; REVIEW; SUBSTITUTION THERAPY; ULTRAFILTRATION;

EID: 0031943829     PISSN: 08850666     EISSN: None     Source Type: Journal    
DOI: 10.1177/088506669801300206     Document Type: Review

References (188)

1. Kaplan AA. Continuous arterio-venous hemofiltration and related therapies. In: Jacobs C, Kjellstrand CM, Koch KM, et al., eds. Replacement of renal function by dialysis, 4th ed. Dordrecht: Kluwer Academic, 1996:390-417
2. Kramer P, Wigger W, Rieger J, et al. Arteriovenous haemofiltration: a new and simple method for the treatment of over-hydrated patients resistant to diuretics. Klinische Wochen-schrift 1977;55:1121-1122
3. Kramer P, Seegers A, De Vivie R, et al. Therapeutic potential of hemofiltration. Clin Nephrol 1979;11:145-149
4. Kramer P, Kaufhold G, Grone HJ, et al. Management of anuric intensive-care patients with arterio-venous hemofiltration. Int J Artif Organs 1980;3:225-230
5. Colton CK, Henderson LW, Ford CA, et al. Kinetics of hemodiafiltration: I. In vitro transport characteristics of a hollow fiber blood ultrafilter. J Lab Clin Med 1975;85:355-371
6. Henderson LW, Colton CK, Ford CA. Kinetics of hemodiafiltration: II. Clinical characterization of a new blood cleansing modality. J Lab Clin Med 1975;85:372-391
7. Nolph KD. Short dialysis, middle molecules and uremia. Ann Intern Med 1977;86:93-97
8. Kaplan AA, Longnecker RE, Folkert VW. Continuous arteriovenous hemofiltration: a report of six month's experience. Ann Intern Med 1984;100:358-367
9. Kaplan AA. Procedure manual: continuous arterio-venous hemofiltration. Clinical protocol from the John Dempsey Hospital, University of Connecticut Health Center, Farmington, CT, 1985
10. Mault JR, Dirkes SM, Swartz RD, et al. Continuous hemofiltration: a reference guide for SCUF, CAVH and CAVHD. University of Michigan Medical Center, Ann Arbor, MI
11. Price CA. Standards of clinical practice for continuous renal replacement therapy. In: Burrows-Hudson S, ed. Standards of clinical practice for nephrology nursing, 3rd ed. Pitman, NJ: American Nephrology Nurses' Association, 1993
12. Paganini EP, Nakamoto S. Continuous slow ultrafiltration in oliguric acute renal failure. Trans Am Soc Artif Intern Organs 1980;26:201-204
13. Paganini E.P. Continuous renal replacement therapy in open heart or artificial heart patients with acute renal failure. In: La Greca G, Fabris A, Ronco C, eds. CAVH: proceedings of the international symposium on continuous arterio-venous hemofiltration. Milan, Italy: Wichtig Editore, 1986:199-226
14. Paganini EP, Flaque J, Whitman G, et al. Amino acid balance in patients with oliguric acute renal failure undergoing slow continuous ultrafiltration (SCUF). Trans Am Soc Artif Intern Organs 1982;28:615-620
15. Paganini EP, O'Hara P, Nakamoto S. Slow continuous ultrafiltration in hemodialysis resistant oliguric acute renal failure patients. Trans Am Soc Artif Intern Organs 984;30: 173-177
16. Desio FJ, Paganini EP. Evaluation of slow continuous ultrafiltration in oliguric patients on intraaortic balloon pumps (abstract). Blood Purif 1984;2:5
17. Paganini EP. Continuous replacement modalities in acute renal dysfunction. In: Paganini EP, ed. Acute continuous renal replacement therapy. Boston: Martinus Nijhoff, 1986: 7-42
18. Paganini EP. Slow continuous ultrafiltration (SCUF). Proceedings of the Third International Symposium on Acute Continuous Renal Replacement Therapy, Fort Luuderdale, Florida, March 1987:37-57
19. Kaplan AA, Longnecker R, Folkert VW. Suction-assisted continuous arteriovenous hemofiltration. Trans Am Soc Artif Intern Organs 1983;24:408-413
20. Domoto DT. Two years clinical experience with continuous arteriovenous hemofiltration in acute renal failure. Trans Am Soc Artif Intern Organs 1985;31:581-585
21. Zobel G, Ring E, Trop M, et al. Suction-supported continuous arteriovenous hemofiltration in children. Blood Purif 1988:6:37-42
22. Golper TA, Kaplan AA, Narasimhan N, et al. Transmembrane pressures generated by filtrate line suction maneuvers and predilution fluid replacement during in vitro continuous arteriovenous hemofiltration. Int J Artif Organs 1987;10:41-46
23. Henderson LW. Pre vs. post dilution hemofiltration. Clin Nephrol 1979;11:120-124
24. Cheung AK, Alford MF, Wilson MW, et al. Urea movement across erythrocyte membrane during artificial kidney treatment. Kidney Int 1983;23:866-869
25. Geronemus R, von Albertini B, Glabman S, et al. Enhanced small molecular clearances in hemofiltration. Proc Clin Dial Transplant Forum 1978;8:147-151
26. Kaplan AA. Predilution vs postdilution for continuous arteriovenous hemofiltration. Trans Am Soc Artif Intern Organs 1985;31:28-32
27. Kaplan AA. Clinical trials with predilution and vacuum suction: enhancing the efficiency of the CAVH treatment. Trans Am Soc Artif Intern Organs 1986;32:49-51
28. Kaplan AA. Enhanced efficiency during CAVH: clinical trials with predilution and suction. In: La Greca G, Fabris A, Ronco C, eds. Milan, Italy: Wichtig Editore, 1986:49-54
29. Kaplan AA. The predilution mode for continuous arteriovenous hemofiltration. In: Paganini EP, ed. Acute continuous renal replacement therapy. Boston: Martinus Nijhoff, 1986: 143-171
30. Geronemus R, Schneider N. Continuous arteriovenous hemodialysis: a new modality for the treatment of acute renal failure. Trans Am Soc Artif Intern Organs 1984;30:610-612
31. Pallone TL, Hyver S, Petersen J. Blood-dialysate equilibrium during continuous arteriovenous hemodialysis. Trans Am Soc Artif Intern Organs 1988;34:512-514
32. Bonnardeaux A, Pichette V, Ouimet D, et al. Solute clearances with high dialysate flow rates and glucose absorption from the dialysate in continuous arteriovenous hemodialysis. Am J Kidney Dis 1992;19:31-38
33. Sigler MH, Teehan BP, Van Valkenburgh D. Solute transport in continuous hemodialysis: a new treatment for acute renal failure. Kidney Int 1987;32:562-571
34. Yohay DA, Schwab SJ, Quarles LD. Parallel plates are more effective than hollow fiber dialyzers in continuous arteriovenous hemodialysis (abstract). J Am Soc Nephrol 1990;1: 382
35. Stevens PE, Riley B, Davies SP, et al. Continuous arteriovenous hemodialysis in critically ill patients. Lancet 1988;ii: 150-152
36. Ronco C. Bragantini L, Brendolan A, et al. Arteriovenous hemodiafiltration (AVHDF) combined with continuous arteriovenous hemofiltration (CAVH). Trans Am Soc Artif Intern Organs 1985;31:349-352
37. Ing TS, Daugirdas H, Bregman H, et al. Continuous arteriovenous hemodialysis (editorial). Int J Artif Organs 1985:8: 117-118
38. Daugirdas JT, Bregman H, Rahman MA, et al. Ultrafiltration control during continuons arteriovenous hemodialysis using paired volumetric dialysate pumps (letter). Int J Artif Organs 1986;9:273
39. van Geelen JA, Vincent HH, Schalekamp MADH. Continuous arteriovenous haemofiltration and haemodiafiltration in acute renal failure. Nephrol Dial Transplant 1988;2: 181-186
40. Gibney RTN, Stollery DE, Lefebvre RE, et al. Continuous arteriovenous hemodialysis: an alternative therapy for acute renal failure associated with critical illness. Can Med Assoc J 1988;139:861-866
41. Pattison ME, Lee SM, Ogden DA. Continuous arteriovenous hemodiafiltration: an aggressive approach to the management of acute renal failure. Am J Kidney Dis 1988;11:43-47
42. Domoto DT, Brown WW, Bruggensmith P. Removal of toxic levels of N-acetylprocainamide with continuous arteriovenous hemofiltration or continuous arteriovenous hemodiafiltration. Ann Intern Med 1987;106:550-552
43. Bellomo R, Kearly Y, Parkin G, et al. Treatment of life threatening lithium toxicity with continuous arteriovenous hemodiafiltration. Crit Care Med 1991;19:836-837
44. Golper TA, Leone M. Backtransport of dialysate solutes during in vitro continuous arteriovenous hemodialysis. Blood Purif 1989;7:223-229
45. Morabito S, Gamberini M, Marzoli G, et al. Efficiency of different hollow-fiber hemofilters in continuous arteriovenous hemodiafiltration (CAVHD) (abstract). J Am Soc Nephrol 1993;4:370
46. Canaud B, Beraud JJ, Mion C. Pump assisted continuous veno-venous hemofiltration (PA-CVVH): a more flexible mode of acute uremia treatment in severely ill patients. In: La Greca G, Fabris A, Ronco C, eds. CAVH: proceedings of the international symposium on continuous arterio-venous hemofiltration. Milan, Italy: Wichtig Editore, 1986:185-189
47. Bouchet JL, Bourdenx JPh, Montoriol J, et al. Continuous veno-venous hemofiltration (CVVH): technical and clinical experience. In: La Greca G, Fabris A, Ronco C. eds. CAVH: proceedings of the international symposium on continuous arterio-venous hemofiltration. Milan, Italy: Wichtig Editore, 1986:319-324
48. Canaud B, Garred LJ, Christol JP, et al. Pump assisted continuous venovenous hemofiltration for treating acute uremia. Kidney Int 1988;33:S154-S156
49. Morgan JM, Morgan C, Evans TW. Clinical experience of pumped arteriovenous haemofiltration in the management of patients in oliguric renal failure following cardiothoracic surgery. Int J Cardiol 1988;21:259-267
50. Wendon J, Smithies M, Sheppard M, et al. Continuous high volume venous-venous haemofiltration in acute renal failure. Intensive Care Med 1989;15:358-363
51. Storck M, Hartl WH, Zimmerer E, et al. Comparison of pump-driven and spontaneous haemofiltration in postoperative acute renal failure. Lancet 1991;i:452-455
52. Macias WL, Mueller BA, Scarim SK, et al. Continuous venovenous hemofiltration: an alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure. Am J Kidney Dis 1991;18:451-458
53. Golper TA, Price J. Continuous veno-venous hemofiltration for acute renal failure in the intensive care setting: technical considerations. Trans Am Soc Artif Intern Organs 1994;40: 936-939
54. Kudoh Y, Iimura O. Slow continuous hemodialysis-new therapy for acute renal failure in critically ill patients-Part 1. Theoretical consideration and new technique. Jap Cir J 1988;52:1171-1182
55. Kudoh Y, Shiiki M, Sasa Y, et al. Slow continuous hemodialysis-new therapy for acute renal failure in critically ill patients-Part 2. Animal experiments and clinical implication. Jap Cir J 1988;52:1183-1190
56. Tarn PYW, Huraib S, Mahan B, et al. Slow continuous hemodialysis for the management of complicated acute renal failure. Clin Nephrol 1988;30:79-85
57. Bellomo R, Parkin G, Love J, et al. A prospective comparative study of continuous arteriovenous hemodiafiltration and continuous venovenous hemodiafiltration in critically ill patients. Am J Kidney Dis 1993;21:400-404
58. Golper TA, Jacobs AA. Pumps utilized during continuous renal replacement therapy. Semin Dialysis 1996;9:119-124
59. Mendelssohn DC, Wong JA, Feng P, et al. Technical experience with the Prisma continuous venovenous renal replacement therapy system (abstract). Blood Purif 1997;15: 139
60. Pallone TL, Hyver S, Petersen J. The simulation of continuous arteriovenous hemodialysis with a mathematical model. Kidney Int 1989;35:125-133
61. Olbricht CJ, Schurek HJ, Stolte H, et al. The influence of vascular access modes on the efficiency of CAVH. In: Sieberth H-G, Mann H, eds. Continuous arteriovenous hemofiltration. Basel, Switzerland: Karger, 1985:14-24
62. Jenkins R, Funk J, Chen B, et al. Effects of access catheter dimensions on bloodflow in continuous arteriovenous hemofiltration. In: Sieberth H-G, Mann H, Stummvoll HK, eds. Contributions to nephrology. Vol. 93 Continuous hemofiltration. Basel, Switzerland: Karger, 1991:171-174
63. Quinton W, Dillard D, Scribner BH. Cannulation of blood vessels for prolonged hemodialysis. Trans Am Soc Artif Intern Organs 1960;6:104-109
64. Zobel G, Trop M, Beitzke A, et al. Vascular access for continuous arteriovenous hemofiltration in infants and young children. Artif Organs 1988;12:16-19
65. Jenkins RD, Kuhn RJ, Funk JR. Clinical implications of catheter variability on neonatal continuous arteriovenous hemofiltration. Trans Am Soc Artif Organs 1988;34:108-111
66. Uldall R. Vascular access for continuous renal replacement therapy. Semin Dial 1996;9:93-97
67. Spinowitz BS, Galler M, Golden RA, et al. Subclavian vein stenosis as a complication of subclavian catheterization for hemodialysis. Arch Intern Med 1987;147:305-307
68. Lysaght MJ, Boggs DR, Ritger P, et al. Membranes and transport phenomena in CAVH and CAVHD. In: La Greca G, Fabris A, Ronco C, eds. CAVH: international symposium on continuous arterio-venous hemofiltration. Milan, Italy: Wichtig Editore, 1986:77-85.
69. Ronco C, Brendolan A. Bragantini L, et al. Treatment of acute renal failure in newborns by continuous arterio-venous hemofiltration. Trans Am Soc Artif Organs. 1985;31: 634-638
70. Ronco C, Bosch JP, Lew S, et al. Technical and clinical evaluation of a new hemofilter for CAVH: theoretical concepts and practical application of a different blood How geometry. In: La Greca G, Fabris A, Ronco C, eds. CAVH: international symposium on continuous arterio-vcnous hemofiltration. Milan, Italy: Wichtig Editore, 1986:55-61
71. Ronco C, Brendolan A, Borin D, et al. Permeability characteristics of polysulfonic membranes in CAVH. In: Sieberth HG, Mann H, eds. Continuous arteriovenous hemofiltration. Basel, Switzerland: Karger, 1985:59-63
72. Jenkins R, Chen B, Funk JE. Maximum ultrafiltration rate in continuous arteriovenous hemofiltration does not occur at the lowest level of the ultra filtrate collection chamber. Am Soc Artif Intern Organs J 1993:39:M618-M620.
73. Voerman HJ, Strack van Schijndel RJM, Thijs LG. Continuous arterial-venous hemodiafiltration in critically ill patients. Crit Care Med 1990;18:911-914
74. Lauer A, Saccaggi A, Ronco C, et al. Continuous arteriovenous heniofiltration in the critically ill patient. Ann Intern Med 1983;99:455-460
75. Lennander O, Mulec H. CAVH by negative suction-what is the optimal pressure? In: La Greca G, Fabris A, Ronco C, eds. CAVH: international symposium on continuous arterio-venous hemofiltration. Milan, Italy: Wichtig Editore, 1986:87-90
76. Ronco C, Brendolan A, Bragantini L, et al. Technical and clinical evaluation of a new polyamide hollow fiber hemofilter for CAVH. Int J Artif Organs 1988;11:33-38
77. Kaplan AA, Golper TA. Sieving characteristics of a new polysulfone hemofilter for use with continuous arteriovenous hemofiltration. Int J Artif Organs 1987;10:357-360
78. Arakawa M, Nagao M, Gejyo F, et al. Development of a new antithrombogenic continuous ultrafiltration system. Artif Organs 1991;15:171-179
79. Sigler MH, Manns M. Membranes and devices used in continuous renal replacement therapy. Semin Dial 1996;9: 98-106
80. Kramer P, Bohler J, Kehr A, et al. Intensive care potential of continuous arteriovenous hemofiltration. Trans Am Soc Artif Organs 1982;28:28-32
81. Kaplan AA, Toueg S, Kennedy TL. Complement kinetics during continuous arteriovenous hemofiltration: studies with a new polysulfone hemofilter. Blood Purif 1988;6:27-36
82. Parnes EL, Shapiro WB. Anaphylactoid reactions in hemodialysis patients treated with AN69 dialyzers. Kidney Int 1991;40:1148
83. Schaefer RM, Fink, F, Schaefer, L, et al. Role of bradykinin in anaphylactoid reactions during hemodialysis with AN69 dialyzers. Am J Nephrol 1993;13:473
84. Paganini E. Continuous replacement modalities in acute renal dysfunction. In: Paganini E, ed. Acute continuous renal replacement therapy: Boston-Martinus Nijhoff, 1986: 7-41
85. Jenkins RD, Jackson E, Kuhn R, et al. Benefit of bicarbonate dialysis during CAVHD. Trans Am Soc Artif Intern Organs 1990;36:M465-M466
86. Olbricht C, Mueller C, Schurek HJ. Treatment of acute renal failure in patients with multiple organ failure by continuous spontaneous hemofiltration. Trans Am Soc Artif Intern Organs 1982;28:33-37
87. Kohen JA, Whitley KY, Kjellstrand CM. Continuous arteriovenous hemofiltration: a comparison with hemodialysis in acute renal failure. Trans Am Soc Artif Intern Organs 1985; 31:169-173
88. Mehta RL, Dobos GJ, Ward DM. Anticoagulation in continuous renal replacement procedures. Semin Dial 1992;5: 61-68
89. Spinowitz B. Anticoagulation in continuous arteriovenous hemofiltration. Proceedings of the Third International Symposium on Acute Continuous Renal Replacement Therapy, Fort Lauderdale, Florida, March 1987:106-110
90. Favre H, Martin PY, Stoermann G. Anticoagulation in continuous extracorporeal renal replacement therapy. Semin Dial 1996;9:112-118
91. Kaplan AA. Continuous arterio-venous hemofiltration and related therapies. In: Jacobs C, Kjellstrand CM, Koch KM, et al. eds. Replacement of renal function by dialysis, 4th ed. Dordrecht: Kluwer Academic, 1996:390-417
92. Kramer P, Schrader J, Bohnsack W, et al. Continuous arteriovenous haemofiltration: a new kidney replacement therapy. Proc Fur Dial Transplant Assoc 1981:18:743-749.
93. Shrader J, Scheler F. Coagulation disorders in acute renal failure and anticoagulation during CAVH with standard heparin and with low molecular weight heparin. In: Sic-berth H-G, Mann H, eds. Continuous arteriovenous hemofiltration. Basel, Switzerland: Karger, 1985:25-36
94. Bull BS, Korpman RA, Huse WM, et al. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols. J Thorac Cardiovasc Surg 1975; 69:674-684
95. Bjornssson TD, Wolfram KM, Kitchell BB. Heparin kinetics determined by three assay methods. Clin Pharmacol Ther 1982;31:104-113
96. Ellison N, Beatty P, Blake DR, et al. Heparin rebound. J Thorac Cardiovas Surg 1974;67:723-729
97. Hampers CL, Blaufox MD, Merill JP. Anticoagulation rebound after hemodialysis. N Eng J Med 1966;275:776-778
98. Milne B, Rodgers K, Cervenko F, et al. Hemodynamic effects of intra-aortic administration versus intravenous administration of protamine for reversal of heparin in man. Can Anaesth Soc J 1983;30:347-351
99. Kaplan AA, Petrillo R. Regional heparinization for continuous arterio-venous hemofiltration (CAVH). Trans Am Soc Artif Intern Organs 1987;33:312-315
100. Hory B, Cachoux A, Toulemonde F. Continuous arteriovenous hemofiltration with low-molecular weight heparin (letter). Nephron 1985;41:125
101. Mehta RL, McDonald BR, Aguilar MM, et al. Regional citrate anticoagulation for continuous arterio-venous hemodialysis in critically ill patients. Kidney Int 1990;38:976-981
102. Zusman RM, Rubin RH, Cato AE, et al. Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. N Eng J Med 1981;304:934-939
103. Smith MC, Danviriyasup K, Crow JW, et al. Prostacyclin substitution for heparin in long-term hemodialysis. Am J Med 1982;73:669-678
104. Zobel G, Trop M, Muntean W, et al. Anticoagulation for continuous arteriovenous hemofiltration in children. Blood Purif 1988;6:90-95
105. Weeden J, Smithies M, Sheppard M, et al. Continuous high volume venous-venous haemofiltration in acute renal failure. Int Care Med 1989;15:358-363
106. Pataca MI, Ramesh BR, Partner A, et al. Continuous arteriovenous haemodialysis in severe combined renal and respiratory failure. Blood Purif 1992; 10:262-268
107. Ponikvar R, Kandus A, Buturovic J, et al. Use of prostacyclin as the only anticoagulant during continuous venovenous hemofiltration. In: Sieberth HG, Mann H, Stummvoll HK, eds. Contributions in nephrology. Vol. 93. Continuous hemofiltration. Basel, Switzerland: Karger, 1992:218-220
108. Forni LG, Hilton PJ. Continuous hemofiltration in the treatment of acute renal failure. N Eng J Med 1997;336: 1303-1309
109. Ohtake Y, Hirasawa H, Sugai T, et al. A study on anticoagulants in continuous hemofiltration. Jpn J Artif Organs 1990; 19:744-748
110. Ohtake Y, Hirasawa H, Sugai T, et al. Nafamostat mesilate as anticoagulant in continuous hemofiltration and continuous hemodiafiltration. In: Sieberth H, Mann H, Stummvol H, eds. Contributions to nephrology. Vol 93. Continuous hemofiltration. Basel, Switzerland: Karger, 1991:215-217
111. Smith D, Paganini EP, Suhoza K, et al. Non-heparin continuous renal replacement therapy is possible. In: Nose Y, Kjellstrand C, Ivanovich P, eds. Progress in artificial organs. Cleveland: ISAO Press, 1986:226-230
112. Martin PY, Chevrolet JC, Suter P, et al. Anticoagulation in patients treated by continuous venovenous hemofiltration: a retrospective study. Am J Kidney Dis 1994;24:806-812
113. Arakawa M, Suzuki Y, Nagao M, et al. Development of a new antithrombogenic continuous ultrafiltration system (ACUS) and its clinical evaluation. Nephrol Dial Transplant 1991;2 (suppl):49-54
114. Sieffert E, Mateo J, Deligeon N, et al. Continuous arteriovenous hemofiltration using heparin-coated and non-heparin-coated membranes in critically ill patients: effects on platelet counts (abstract). Blood Purif 1997;15:141
115. Teschan PE, Baxter CR, O'Brien TF, et al. Prophylactic hemodialysis in the treatment of acute renal failure. Am J Med 1960;53:992-1016
116. Kleinknecht D, Jungers P, Chanard J, et al. Uremic and non-uremic complications in acute renal failure. Kidney Int 1972;1:190-196
117. Conger JD. A controlled evaluation of prophylactic dialysis in post-traumatic acute renal failure. J Trauma 1975;15: 1056-1063
118. Gillium DM, Dixon BS, Yanover MJ, et al. The role of intensive dialysis in acute renal failure. Clin Nephrol 1986; 25:249-255
119. Kaplan AA. Extracorporeal blood purification in the treatment of acute renal failure with multiorgan involvement. Blood Purif 1996; 14:86-93
120. Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 1985;27:58-65
121. Sigler MH, Samuel S, Teehan BP. Amino acid removal during continuous arterio-venous hemodialysis (CAVHD) in acute renal failure patients receiving total parenteral nutrition (abstract). Blood Purif 1988;6:357
122. Bartlett RH, Mault JR, Dechert RE, et al. Continuous arteriovenous hemofiltration: improved survival in surgical acute renal failure? Ann Surg 1986;100:400-408
123. Bellomo R, Mansfield D, Rumble S, et al. Conventional dialysis versus acute continuous hemodiafiltration. Am Soc Artif Intern Organs J 1992;38:M654-M657
124. Clark WR, Murphy MH, Alaka KJ, et al. Urea kinetics during continuous hemofiltration. Am Soc Artif Intern Organs J 1992;38:M664-M667
125. Clark WR, Mueller BA, Alaka KJ, et al. A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. J Am Soc Nephrol 1994;4:1413-1420
126. Kramer P, Bohler J, Kehr A, et al. Intensive care potential of continuous arteriovenous hemofiltration. Trans Am Soc Artif Intern Organs 1982;28:28-32
127. Chima SC, Meyer L, Hummell C, et al. Protein catabolic rate in patients with acute renal failure on continuous arteriovenous hemofiltration and total parenteral nutrition. J Am Soc Nephrol 1993;3:1516-1521
128. Davenport A, Roberts NB. Amino acid losses during continuous high-flux hemofiltration in the critically ill patient. Crit Care Med 1989;17:1010-1013
129. Davies SP, Reaveley DA, Brown EA, et al. Amino acid clearances and daily losses in patients with acute renal failure treated by continuous arteriovenous hemodialysis. Crit Care Med 1991;19:1510-1515
130. Mokrzycki MH, Kaplan AA. Protein losses during continuous renal replacement therapy. J Am Soc Nephrol 1996;7: 2259-2263
131. Golper TA, Wedel SK, Kaplan AA, et al. Drug removal during continuous arteriovenous hemofiltration: theory and clinical observations. Int J Artif Organs 1985;8:307-312
132. Golper TA, Pulliam J, Bennett WM. Removal of therapeutic drugs by continuous arteriovenous hemofiltration. Arch Intern Med 1985;145:1651-1652
133. Kronfol NO, Lau AH, Colon-Rivera J, et al. Effect of CAVH membrane types on drug-sieving coefficients and clearances. Trans Am Soc Artif Intern Organs 1986;2:85-87
134. Reyad S, Barajas M, Swartz, RD, et al. Drug removal during continous arteriovenous hemofiltration. Contemp Dial Nephrol 1989;May:30-42
135. Lau AH, Pyle K, Kronfol NO, et al. Removal of cephalosporins by continuous arteriovenous ultrafiltration (CAVU) and hemofiltration (CAVH). Int J Artif Organs 1989;12:379-383
136. Bellomo R, McGrath B, Boyce N. In vivo catecholamine extraction during continuous hemodiafiltration in inotrope-dependent patients. Trans Ara Soc Artif Intern Organs 1991; 37:M324-M325
137. Mueller BA, Scarim SK, Macias WL. Comparison of imipenem pharmacokinetics in patients with acute or chronic renal failure treated with continuous hemofiltration. Am J Kidney Dis 1993;21:172-179
138. Bennet WM, Aronoff GR, Golper TA, et al. Drug rescribing in renal failure, 2nd ed. Philadelphia: American College of Physicians, 1991
139. Kroh UF, Holl TJ, Steinhdausser W. Management of drug dosing in continuous renal replacement therapy. Semin Dial 1996;9;161-165
140. Kaplan AA, Longnecker RE, Folkert VW. Continuous hemofiltration (letter). Ann Intern Med 1984;101:145-146
141. Golper TA, Marx M, Shuler C, et al. Drug dosage in dialysis patients. In: Jacobs C, Kjellstrand CM, Koch KM, et al. eds. Replacement of renal function by dialysis, 4th ed. Dordrecht: Kluwer Academic, 1996:750-820
142. Reynolds HN. Complications related to the use of continuous arterio-venous hemofiltration with dialysis (abstract). Crit Care Med 1990;18:S192
143. Kramer P. Limitations and pitfalls of continuous arteriovenous hemofiltration. In: Kramer P, ed. Arteriovenous hemofiltration: a kidney replacement therapy for the intensive care unit. Berlin-Heidelberg: Springer-Verlag, 1985: 206-212
144. Ronco C, Brendolan A, Bragantini L, et al. Treatment of acute renal failure in the newborn by continuous arteriovenous hemofiltration. Kidney Int 1986;29:908-915
145. Ronco C, Brendolan A, Bragantini S, et al. Treatment of acute renal failure in the newborn by continuous arteriovenous hemofiltration. In: La Greca G, Fabris A, Ronco C, eds. CAVH: proceedings of the international symposium on continuous arterio-venous hemofiltration. Milan, Italy: Wichtig Editore, 1986:263-276
146. Zobel G, Trop M, Ring E, et al. Nine months experience with CAVH in a pediatric intensive care unit. In: La Greca G, Fabris A, Ronco C, eds. CAVH: proceedings of the international symposium on continuous arterio-venous hemofiltration. Milan, Italy: Wichtig Editore, 1986:155-161
147. Leone MR, Jenkins RD, Golper TA, et al. Early experience with continuous arteriovenous hemofiltration in critically ill pediatric patients. Crit Care Med 1986;14:1058-1063
148. Jenkins R. Special issues with continuous renal replacement therapy in pediatric patients. Semin Dial 1996;9:179-183
149. Coraim F, Fasol R, Stellwag F, et al. Continuous arteriovenous hemofiltration after cardiac surgery. In: Sieberth HG, Mann H, eds. Contributions to nephrology. Vol. 93. Continuous arteriovenous hemofiltration. Basel, Switzerland: Karger, 1985:116-124
150. Coraim F, Wolner E. Management of cardiac surgery patients with continuous arteriovenous hemofiltration. In: Sieberth HG, Mann H, eds. Contributions to nephrology. Vol. 93. Continuous arteriovenous hemofiltration. Basel, Switzerland: Karger, 1985:103-110
151. Coraim FJ, Coraim HP, Ebermann R, et al. Acute respiratory failure after cardiac surgery: clinical experience with the application of continuous arteriovenous hemofiltration. Crit Care Med 1986; 14:714-718
152. Bellomo R, Tippiong P, Boyce N. Tumor necrosis factor clearances during veno-venous hemodiafiltration in the critically ill. Am Soc Artif Intern Organs 1991:37: M322-M323
153. Cottrell AC, Mehta RL. Cytokine kinetics in septic ARF patients on continuous veno-veno hemodialysis (abstract). J Am Soc Nephrol 1992;3:279
154. Gomez A, Wang R, Unruh H, et al. Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 1990:73:671-685
155. Stein B, Pfenninger E, Grunert A, et al. The consequences of continuous hemofiltration on lung mechanics and extra-vascular lung water in a porcine endotoxic shock model. Intensive Care Med 1991;17:293-298
156. Grootendorst AF, van Bommel EFH . The role of hemofiltration in the critically-ill intensive care unit patient: present and future. Blood Purif 1993;11:209-223
157. Journois D, Silvester W. Continuous hemofiltration in patients with sepsis or multiorgan failure. Semin Dial 1996; 9:173-178
158. Grootendorst AF, van Bommel EFH, van der Hoven B, et al. High volume hemofiltration improves hemodynamics of endotoxin-induced shock in the pig. J Crit Care 1992;7: 67-72
159. Grootendorst AF, van Bommel EFH, van der Hoven B, et al. High volume hemofiltration improves right ventricular function of endotoxin-induced shock in the pig. Intensive Care Med 1992; 18:235-240
160. van Bommel EFH, Grootendorst AF, van Leengoed LAMG. Influence of high-volume hemofiltration on hemodynamics in porcine endotoxic shock (abstract). Blood Purif 1992; 10:88
161. Grootendorst AF, van Saase JL. The role of continuous renal replacement therapy in sepsis and multiorgan failure. Am J Kidney Dis 1996;128 (suppl 3): S50-S57
162. Schetz M, Ferdinande P, Van den Berghe G, et al. Removal of pro-inflammatory cytokines with renal replacement therapy: sense or non-sense? Intensive Care Medicine 1995;21: 169-176
163. Misler S, Nidus BD. Long-term ultrafiltration as a treatment of refractory congestive heart failure. NY State J Med 1984: 84;518-520
164. Inoue T, Morooka S, Hayashi T, et al. Effectiveness of continuous arterio-venous hemofiltration (CAVH) for patients with refractory heart failure (abstract). Jpn Circul J 1988; 52:772
165. Kaplan AA. Enhanced efficiency during CAVH: clinical trials with predilution and vacuum suction. In: La Greca G, Fabris A, Ronco C, eds. CAVH: proceedings of the international symposium on continuous arterio-venous hemofiltration. Milan, Italy: Wichtig Editore, 1986:87-90
166. Bergerone S, Tognarelli G, Pacitti A, et al. Ultrafiltration in the treatment of refractory congestive heart failure. In: La Greca G, Fabris A, Ronco C, eds. CAVH: proceedings of the international symposium on continuous arterio-venous hemofiltration. Milan, Italy: Wichtig Editore, 1986:247-253
167. DiLeo M, Pacitti A, Bergerone S, et al. Ultrafiltration in the treatment of refractory congestive heart failure. Clin Cardiol 1988;11:449-452
168. Lauer A, Alvis R, Avram M. Hemodynamic consequences of continuous arterio-venous hemofiltration. Am J Kidney Dis 1988;12:110-115
169. Biasoli S, Barbaresi F, Barbiero M, et al. Intermittent venovenous hemofiltration as a chronic treatment for refractory and intractable heart failure. Am Soc Artif Intern Organs J 1992;38:M658-M663
170. Davenport A, Will EJ, Losowsky MS, et al. Continuous arteriovenous haemofiltration in patients with hepatic encephalopathy and renal failure. Lancet 1987;ii:295
171. Davenport A, Will FJ, Davison AM, et al. Changes in intra- cranial pressure during haemofiltration in oliguric patients with grade IV hepatic encephalopathy. Nephron 1989;53: 142-146
172. Davenport A. The management of established renal failure in patients with liver failure. Semin Dial 1996;9:166-172
173. Matsubara S, Kenji O, Kiyoaki O, et al. Continuous removal of middle molecules by hemofiltration in patients with acute liver failure. Crit Care Med 1990;18:1331-1338
174. Bellomo R, Harris C, Kang Y, et al. Combined veno-venous bypass and high volume hemofiltration during orthotopic liver transplantation. Am Soc Artif Intern Organs 1993;39: 954-956
175. Gil-Vernet S, Grinjyo JM, Andres E, et al. Intraoperative dialysis in combined liver-kidney transplantation (abstract). Blood Purif 1995;13:402
176. Benjamin E, Geffroy V, Oropello J, et al. Continuous venovenous hemofiltration in patients with hepatic failure and orthotopic liver transplantation (abstract). Blood Purif 1995; 13:401
177. Hammer G, Conley S, So S, et al. CVVH-D in combination with total hepatectomy and portocaval shunting-bridge to liver transplantation (abstract). Blood Purif 1995;13: 400-401
178. Golper TA, Bennett WM. Drug removal by continuous arteriovenous hemofiltation-a review of the evidence in poisoned patients. Med Toxicol Adverse Drug Exp 1988;3: 341-349
179. Raimondi F, Bianchi T, Emmi V, et al. Use of continuous arterio-venous hemofiltration in lactic acidosis. In: La Greca G, Fabris A, Ronco C, eds. CAVH: proceedings of the international symposium on continuous arterio-venous hemofiltration. Milan, Italy: Wichtig Editore, 1986:135-137
180. Kohn OK, Kaplan AA. High bicarbonate solutions in the treatment of lactic acidosis with continuous renal replacement therapy (CVVH and CVVHD) (abstract). J Am Soc Nephrol 1995:6:495
181. Kirschbaum B, Galishoff M, Reines HD. Lactic acidosis treated with continuous hemodiafiltration and regional citrate anticoagalation. Crit Care Med 1992;20:349-353
182. Schou H, Knudsen F. Continuous arteriovenous hemofiltration-a new treatment in hypercalcemic crisis. Blood Purif 1988,6:227-229
183. Kramer P, Biege G. Intensive care potentials of continuous arteriovenous hemofiltration. In: Kramer P, ed. Arteriovenous hemofiltration: kidney replacement therapy for the intensive care unit. Berlin: Springer-Verlag. 1985:196-199
184. Kruczyn.ski K, Irvine-Bird K, Toffelmire EB, et al. A comparison of continuous arteriovenous hemofiltration and intermittent hemodialysis in acute renal failure patients in the intensive care unit. Am Soc Artif Intern Organs J 1993;39: M778-M781
185. Mehta R, McDonald B, Gabbai F, et al. Continuous versus intermittent dialysis for acute renal failure in the ICU. Results of a randomized multicenter trial (abstract). J Am Soc Nephrol 1996;7:1457
186. Bellomo R, Boyce N. Does continuous hemodiafiltration improve survival in acute renal failure. Semin Dial 1993; 6:16-19
187. Cerra FB, Negro F, Abrams J. Apache II score does not predict multiple organ failure or mortality in postoperative surgical patients. Arch Surg 1990;125:519-522
188. Le Gall JR, Lemeshow S. Do we need a new severity score? Crit Care Med 1991;19:857-858